Nasdaq: VIR
Vir Biotechnology insiders
The officers, directors and 10% owners of Vir Biotechnology, Inc. who hold the most stock, valued at the live VIR price.
$8.87
VIR today −$280K (−3.06%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 8
- Their VIR stock
- $155M
- Market value
- $1.65B
- Held by ranked insiders
- 9.38%
Insiders by value of VIR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | ARCH Venture Fund IX, L.P. | 10% owner | 6,144,428 | $54.5M | 3.30% | Corporate |
| 2 | ARCH Venture Partners IX, L.P. | 10% owner | 5,717,738 | $50.7M | 3.07% | Corporate |
| 3 | George A. Scangos | Director | 2,661,798 | $23.6M | 1.43% | 3690th |
| 4 | Vicki L. Sato | Director | 1,078,391 | $9.6M | 0.58% | 7843rd |
| 5 | Backer Marianne De | President and CEO | 1,054,381 | $9.4M | 0.57% | 8333rd |
| 6 | Robert Nelsen | Director | 618,041 | $5.5M | 0.33% | 13445th |
| 7 | Phillip A. Sharp | Director | 165,618 | $1.5M | <0.1% | 2946th |
| 8 | Ramy Farid | Director | 32,000 | $284K | <0.1% | 8182nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Vir Biotechnology; see each profile for the filing.